{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:15:15Z","timestamp":1789917315686,"version":"4.0.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1136\/ard.54.3.197","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"197-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study."],"prefix":"10.1016","volume":"54","author":[{"given":"J.J.","family":"Belch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Capell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.D.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Madhok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"183","key":"ref_1","first-page":"187","article-title":"Raynaud's disease: A critical review of minimal requisites for diagnosis","volume":"1932","author":"V, Allen E.; E, Brown G.","unstructured":"Allen E V, Brown G E. Raynaud's disease: A critical review of minimal requisites for diagnosis. Am J7 Med Sci 1932; 183: 187-200.","journal-title":"Am J7 Med Sci"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/rheumatology\/29.3.162","article-title":"The phenomenon syndrome and disease of Maurice Raynaud","volume":"29","author":"F, Belch J.J.","year":"1991","unstructured":"Belch J J F. The phenomenon syndrome and disease of Maurice Raynaud. BrJ Rheumatol 1991; 29: 162-5.","journal-title":"BrJ Rheumatol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1056\/NEJM198304143081507","article-title":"Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon","volume":"308","author":"J, Rodeheffer R.; A, Rommer J.; F, Wigley; R, Smith C.","year":"1983","unstructured":"Rodeheffer R J, Rommer J A, Wigley F, Smith C R. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J7 Med 1983; 308: 880-3.","journal-title":"N Engl J7 Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bmj.298.6673.561","article-title":"Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study","volume":"298","author":"Rademaker, M.; D, Cooke E.; E, Almond N.","year":"1989","unstructured":"Rademaker M, Cooke E D, Almond N E, et al. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. BMJ 1989; 298: 561-4.","journal-title":"BMJ"},{"key":"ref_5","first-page":"313","article-title":"Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome","volume":"i:","author":"F, Belch J.J.; P, Newman; K, Drury J.","year":"1981","unstructured":"Belch J J F, Newman P, Drury J K, et al. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. Lancet 1981; i: 313-5.","journal-title":"Lancet"},{"key":"ref_6","first-page":"106","article-title":"Therapy of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)","volume":"81","author":"M, Dowd P.; R, Martin M.F.; D, Cooke E.","year":"1982","unstructured":"Dowd P M, Martin M F R, Cooke E D, et al. Therapy of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2). BrJDermatol 1982; 81: 106-10.","journal-title":"BrJDermatol"},{"key":"ref_7","first-page":"617","article-title":"Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis","volume":"63","author":"Rademaker, M.; M, Thomas R.H.; Provost, G.; A, Beacham J.; D, Cooke E.; KirbyJ, D.","year":"1987","unstructured":"Rademaker M, Thomas R H M, Provost G, Beacham J A, Cooke E D, KirbyJ D. Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis. PostgradMedJ 1987; 63: 617-20.","journal-title":"PostgradMedJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/ard.50.11.800","article-title":"A double blind, randomised, multi center comparison of 2 doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases","volume":"50","author":"I, Torley H.; R, Madhok; A, Capell H.","year":"1991","unstructured":"Torley H I, Madhok R, Capell H A, et al. A double blind, randomised, multi center comparison of 2 doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis 1991; 50: 800-4.","journal-title":"Ann Rheum Dis"},{"key":"ref_9","first-page":"1407","article-title":"Placebo controlled pilot study of intravenous iloprost in patients with Raynaud's phenomenon secondary to systemic sclerosis","volume":"19","author":"R, Seibold J.; M, Wigley F.","year":"1992","unstructured":"Seibold J R, Wigley F M. Placebo controlled pilot study of intravenous iloprost in patients with Raynaud's phenomenon secondary to systemic sclerosis. Jf Rheumatol 1992; 19: 1407-14.","journal-title":"Jf Rheumatol"},{"issue":"3","key":"ref_10","first-page":"320","article-title":"Raynaud's disease and pre-ganglionic sympathectomy","volume":"1938","author":"Lewis, T.","unstructured":"Lewis T. Raynaud's disease and pre-ganglionic sympathectomy. Clin Sci 1938; 3: 320-36.","journal-title":"Clin Sci"},{"key":"ref_11","first-page":"346","article-title":"Platelet sensitivity to a prostacyclin analogue in systemic sclerosis","volume":"24","author":"F, Belch J.J.; A, O.'Dowd; D, Forbes C.; D, Sturrock R.","year":"1987","unstructured":"Belch J J F, O'Dowd A, Forbes C D, Sturrock R D. Platelet sensitivity to a prostacyclin analogue in systemic sclerosis. BrJRheumatol 1987; 24: 346-50.","journal-title":"BrJRheumatol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.1981.tb01203.x","article-title":"Detection of immune complexes in systemic sclerosis and Raynaud's phenomenon","volume":"105","author":"M, Dowd P.","year":"1981","unstructured":"Dowd P M, Kirby J D, Holborow E J, Cooke E D, Bowcock S A. Detection of immune complexes in systemic sclerosis and Raynaud's phenomenon. Br J Dermatol 1981; 105: 179-88.","journal-title":"Br J Dermatol"},{"key":"ref_13","first-page":"97","article-title":"The effect of ZK36374 (Iloprost) on white cell behaviour","volume-title":"its stable analogue iloprost","author":"F, Belch J.J.; A, Saniabadi; D, Forbes C.","year":"1986","unstructured":"Belch J J F, Saniabadi A, Forbes C D. The effect of ZK36374 (Iloprost) on white cell behaviour. In: Schror K, Gryglewski R J, eds. Prostacyclin and its stable analogue iloprost. Berlin: Springer Verlag, 1986; 97-102."},{"key":"ref_14","first-page":"97","article-title":"Effect of Iloprost (ZK 36374) on white cell behaviour","volume-title":"its stable analogue iloprost","author":"F, Belch J.J.; A, Saniabadi; R, Dickson; D, Sturrock R.; D, Forbes C.","year":"1987","unstructured":"Belch J J F, Saniabadi A, Dickson R, Sturrock R D, Forbes C D. Effect of Iloprost (ZK 36374) on white cell behaviour. In: Gryglewski R J, Stock G, eds. Prostacyclin and its stable analogue iloprost. Berlin: Springer Verlag, 1987; 97-102."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/bmj.283.6287.350","article-title":"on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis","volume":"283","author":"M, Dowd P.; B, Kovacs I.; H, Bland C.J.; of prostaglandins I, Kirby J.D.T.Effect; E.","year":"1981","unstructured":"Dowd P M, Kovacs I B, Bland C J H, Kirby J D T. Effect of prostaglandins I, and E, on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis. BMJ 1981; 283: 350.","journal-title":"BMJ"},{"key":"ref_16","first-page":"25","article-title":"Treatment of pulmonary embolism with prostacyclin","volume":"88","author":"Utsunomiya, T.; M, Kransz M.; R, Valeri C.; Shepro, D.; B, Hechtman H.","year":"1980","unstructured":"Utsunomiya T, Kransz M M, Valeri C R, Shepro D, Hechtman H B. Treatment of pulmonary embolism with prostacyclin. Surgery 1980; 88: 25-30.","journal-title":"Surgery"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0090-6980(84)90114-X","article-title":"The effrects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers","volume":"28","author":"F, Belch J.J.; I, Greer; M, McLaren","year":"1984","unstructured":"Belch J J F, Greer I, McLaren M, et al. The effrects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers. Prostaglandins 1984; 28: 67-77.","journal-title":"Prostaglandins"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724403269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724403269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.54.3.197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:32:42Z","timestamp":1737545562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724403269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["S0003496724403269"],"URL":"https:\/\/doi.org\/10.1136\/ard.54.3.197","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1995,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.54.3.197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1995 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}